Cargando…
Psoriasis and neurodegenerative diseases—a review
Psoriasis is a chronic skin disease with underlying genetic, inflammatory and immunological background, which is a great medical problem, currently regarded as a systemic condition. Neurodegenerative diseases (NDs) are characterized by a progressive loss of nervous tissue, which affects elderly peop...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549431/ https://www.ncbi.nlm.nih.gov/pubmed/36226313 http://dx.doi.org/10.3389/fnmol.2022.917751 |
_version_ | 1784805670163316736 |
---|---|
author | Nowowiejska, Julia Baran, Anna Flisiak, Iwona |
author_facet | Nowowiejska, Julia Baran, Anna Flisiak, Iwona |
author_sort | Nowowiejska, Julia |
collection | PubMed |
description | Psoriasis is a chronic skin disease with underlying genetic, inflammatory and immunological background, which is a great medical problem, currently regarded as a systemic condition. Neurodegenerative diseases (NDs) are characterized by a progressive loss of nervous tissue, which affects elderly people more frequently; therefore, it is suspected that, due to society's aging, morbidity is going to increase. We performed a thorough review in order to investigate for the first time whether psoriasis may predispose to different particular neurodegenerative diseases—Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). PubMed search resulted in the retrieval of 833 records, of which 77 eligible were included in the review. Our thorough analysis revealed there are some potential links between psoriasis and NDs (inflammation, oxidative stress, genetics, cardiometabolic disorders), but there is no strong evidence that psoriasis may predispose to NDs. Based on the evidence, it seems that the risk of PD in psoriatics is not increased, and the evidence for increased risk of AD slightly prevails the data that state the opposite. ALS risk does not seem to be increased in psoriatics. The paucity of original studies does not allow for the formulation of definitive conclusions but encourages to perform further investigations. |
format | Online Article Text |
id | pubmed-9549431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95494312022-10-11 Psoriasis and neurodegenerative diseases—a review Nowowiejska, Julia Baran, Anna Flisiak, Iwona Front Mol Neurosci Molecular Neuroscience Psoriasis is a chronic skin disease with underlying genetic, inflammatory and immunological background, which is a great medical problem, currently regarded as a systemic condition. Neurodegenerative diseases (NDs) are characterized by a progressive loss of nervous tissue, which affects elderly people more frequently; therefore, it is suspected that, due to society's aging, morbidity is going to increase. We performed a thorough review in order to investigate for the first time whether psoriasis may predispose to different particular neurodegenerative diseases—Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). PubMed search resulted in the retrieval of 833 records, of which 77 eligible were included in the review. Our thorough analysis revealed there are some potential links between psoriasis and NDs (inflammation, oxidative stress, genetics, cardiometabolic disorders), but there is no strong evidence that psoriasis may predispose to NDs. Based on the evidence, it seems that the risk of PD in psoriatics is not increased, and the evidence for increased risk of AD slightly prevails the data that state the opposite. ALS risk does not seem to be increased in psoriatics. The paucity of original studies does not allow for the formulation of definitive conclusions but encourages to perform further investigations. Frontiers Media S.A. 2022-09-26 /pmc/articles/PMC9549431/ /pubmed/36226313 http://dx.doi.org/10.3389/fnmol.2022.917751 Text en Copyright © 2022 Nowowiejska, Baran and Flisiak. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Neuroscience Nowowiejska, Julia Baran, Anna Flisiak, Iwona Psoriasis and neurodegenerative diseases—a review |
title | Psoriasis and neurodegenerative diseases—a review |
title_full | Psoriasis and neurodegenerative diseases—a review |
title_fullStr | Psoriasis and neurodegenerative diseases—a review |
title_full_unstemmed | Psoriasis and neurodegenerative diseases—a review |
title_short | Psoriasis and neurodegenerative diseases—a review |
title_sort | psoriasis and neurodegenerative diseases—a review |
topic | Molecular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549431/ https://www.ncbi.nlm.nih.gov/pubmed/36226313 http://dx.doi.org/10.3389/fnmol.2022.917751 |
work_keys_str_mv | AT nowowiejskajulia psoriasisandneurodegenerativediseasesareview AT barananna psoriasisandneurodegenerativediseasesareview AT flisiakiwona psoriasisandneurodegenerativediseasesareview |